Is RARE stock a Buy, Sell, or Hold?

Based on our analysis, RARE is currently a HOLD with moderate confidence. 📊 HOLD: RARE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of RARE stock?

Our analysis estimates the fair value range for RARE to be between $20.19 and $22.72. The current price is $19.70.

What is the analyst price target for RARE?

The average Wall Street analyst price target for RARE is $52.45. This implies a potential upside of 170.6% from current levels.

RARE Stock Analysis: Buy, Sell, or Hold?

RARE - Ultragenyx Pharmaceutical Inc.

PHARMACEUTICAL PREPARATIONS

$19.71

0.32 (1.68%) ▲

5d: -2.79%

30d: -15.75%

90d: -42.37%

HOLD

MODERATE Confidence

Protect Your RARE Gains

Analysis Updated: Mar 27, 2026 12:00 AM ET

Earnings: May 05, 2026

Smart Money Accumulation

RARE is down 13.0% this week, but smart money is accumulating calls. Top strike: $25 2026-05-15 with 2,213 OI. Call ratio: 91% View Scanner →

Strength: 10.0/10

Get Alerted When RARE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: RARE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

In-depth Analysis How we analyze

Valuation Analysis: RARE is currently trading at $19.70, which is considered oversold relative to its 30-day fair value range of $20.19 to $22.72. The stock's valuation (Forward PE: 239.6) is in line with its historical norms (256.6). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, RARE is in a strong downtrend. Immediate support is located at $18.29, while resistance sits at $22.20.

Market Sentiment: RARE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $52.45 (+170.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD

Fair Price Range $20.19 - $22.72

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 57.1%

Protect Your Profits

Holding RARE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BULLISH: Price oversold vs 30-day range
BEARISH: Weak technical setup (25/100)
BULLISH: High volume confirmation
BULLISH: Trading 170.6% below Wall St target ($52.45)

Fair Price Analysis

30-Day Fair Range $20.19 - $22.72

Current vs Fair Value OVERSOLD

Support & Resistance Levels

Support Level $18.29

Resistance Level $22.20

Current Trend Strong Downtrend

Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) 239.56

Wall Street Target $52.45 (+170.6%)

Revenue Growth (YoY) 25.9%

Profit Margin -85.4%

Valuation Discount vs History -2.3% cheaper

PE vs Historical 239.6 vs 256.6 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -2.3% (market-implied from PE analysis)

1-Year Target $18.93 (-2%)

2-Year Target $18.50 (-5%)

3-Year Target $18.07 (-7%)

3-Yr Target (if PE normalizes) (PE: 240→257) $19.36 (0%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 239.6 to 256.6

Stabilization Target: $20.76 (+7.1%)

PE Expansion Potential: +7.1%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: March 30, 2026 9:59 AM ET
Data refreshes hourly during market hours. Next update: 10:59 AM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is RARE showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Howard Horn SELL 1635 shares 2026-03-03

Emil D Kakkis SELL 54404 shares 2026-03-02

Eric Crombez SELL 7029 shares 2026-03-02

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for RARE.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$411	47 HOLD
INSM Insmed Inc	STRONG BUY 19 analysts	$213	61 BUY
ACLX Arcellx Inc	STRONG BUY 18 analysts	$111	57 HOLD
GPCR Structure Therapeutics I…	STRONG BUY 14 analysts	$109	51 HOLD
IMVT Immunovant Inc	STRONG BUY 14 analysts	$40	58 HOLD

GPCR Structure Therape…

51 HOLD

IMVT Immunovant Inc

58 HOLD

Advanced RARE Option Strategies

Professional options setups generated by AI based on today's RARE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RARE

RARE Technical Chart RARE Price Prediction RARE Earnings Date RARE Investment Advisor RARE Fair Price Analyzer RARE Options Advisor RARE Options Chain RARE Options Analysis RARE Competitors

Compare RARE with Other Stocks

RARE vs TNGX

RARE vs MRK
Winner: MRK

RARE vs NVS
Winner: Tie

RARE vs AZN

RARE vs PFE
Winner: PFE

RARE vs JNJ

Create New Comparison

Tradestie